IL13, Human (Tralokinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IL13, Human (Tralokinumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIL13, Human (Tralokinumab biosimilar)
CloneTralokinumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 lambda
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, FCM, IP, FuncS, IF, Neut
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IL13 Recombinant Antibody (Tralokinumab). Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, [1] and is designed for the treatment of asthma and other inflammatory diseases.[2] Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354[3] and taken through pre-clinical and early clinical development.
Immunogenn/a
Other NamesAnti-IL13 Recombinant Antibody, Research Grade Tralokinumab, Anti-Human IL13 Recombinant Antibody(Tralokinumab), CAT-354, Antibody Drug Analogues, Monoclonal Antibody, YR1107, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1044515-88-9
Catalog #YR1107
Priceplease inquire
Order / More InfoIL13, Human (Tralokinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.